CRMD Q1 2024 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$818,539

Operating Income

-$17M

Net Income

-$14M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$68M

Total Liabilities

$10M

Stockholders' Equity

$58M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$818,539	-$49,445	-1555.5%
Operating Income	-$17M	-$11M	-51.6%
Net Income	-$14M	-$11M	-36.9%